| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-09-25 | NCT07843017 Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia | Phase 2/3 | Not Yet Recruiting |
| Early Phase 1 | 1 | |
| Phase 2/3 | 2 | |
| Phase 4 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06892197 | Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP) | Community Acquired Pneumonia (CAP) | Recruiting | 2026-03-18 |
| NCT06892210 | Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive… | Chronic Obstructive Pulmonary Disease (COPD) | Recruiting | 2026-03-18 |
| Phase 2/3 | ||||
| NCT07843017 | Inhaled Lexofloxacin vs Usual Care for Treatment of Community-Acquired Pneumonia | Community-acquired Pneumonia | Not Yet Recruiting | 2026-09-30 |
| NCT06859450 | Local Antibiotic Delivery for Community Acquired Pneumonia | Community Acquired Pneumonia (CAP) | Not Yet Recruiting | 2025-03-10 |
| Early Phase 1 | ||||
| NCT05921448 | Vaccine Pandemic Preparedness Through Airway Immunology Characterization | Influenza, Human | Active, Not Recruiting | 2026-03-25 |